Anti–factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01/2010 study
Open Access
- 12 May 2016
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 127 (19), 2289-2297
- https://doi.org/10.1182/blood-2015-09-672774
Abstract
Key Points This study is the first to assess the prognostic value of FVIII-specific antibody data in patients with AHA. Anti-FVIII IgA, but not immunoglobulin G, autoantibodies at baseline are potential predictors of recurrence and poor outcome of AHA.Keywords
This publication has 23 references indexed in Scilit:
- Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 studyBlood, 2015
- Management of acquired haemophilia AHamostaseologie, 2015
- Laboratory Diagnosis of Acquired Hemophilia A: Limitations, Consequences, and ChallengesSeminars in Thrombosis and Hemostasis, 2014
- Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patientsBlood, 2013
- Pregnancy‐associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registryBJOG: An International Journal of Obstetrics and Gynaecology, 2012
- Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)Journal of Thrombosis and Haemostasis, 2012
- Improvements in Factor VIII Inhibitor Detection: From Bethesda to NijmegenSeminars in Thrombosis and Hemostasis, 2009
- A population based, unselected, consecutive cohort of patients with acquired haemophilia ABritish Journal of Haematology, 2003
- 9 Acquired inhibitorsBailliere's Clinical Haematology, 1996
- The Mode of Action of Antibodies which Destroy Factor VIII.British Journal of Haematology, 1972